National rates and disparities in childhood vaccination and vaccine-preventable disease during the COVID-19 pandemic: English sentinel network retrospective database study.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
08 2022
Historique:
received: 03 12 2021
accepted: 07 02 2022
pubmed: 2 4 2022
medline: 22 7 2022
entrez: 1 4 2022
Statut: ppublish

Résumé

To describe rates and variation in uptake of pneumococcal and measles, mumps and rubella (MMR) vaccines in children and associated change in vaccine-preventable diseases (VPDs) across the first and second waves of the COVID-19 pandemic. Retrospective database study of all children aged <19 registered with a general practice in the Oxford Royal College of General Practitioners Research and Surveillance Centre English national sentinel surveillance network between 2 November 2015 and 18 July 2021. Coverage of booster dose of pneumococcal vaccine decreased from 94.5% (95% CI 94.3% to 94.7%) at its height on International Organization for Standardization (ISO) week 47 (2020) to 93.6% (95% CI 93.4% to 93.8%) by the end of the study. Coverage of second dose of MMR decreased from 85.0% (95% CI 84.7% to 85.3%) at its height on ISO week 37 (2020) to 84.1% (95% CI 83.8% to 84.4%) by the end of the study. The break point in trends for MMR was at ISO week 34 (2020) (95% CI weeks 32-37 (2020)), while for pneumococcal vaccine the break point was later at ISO week 3 (2021) (95% CI week 53 (2020) to week 8 (2021)). Vaccination coverage for children of white ethnicity was less likely to decrease than other ethnicities. Rates of consultation for VPDs fell and remained low since August 2020. Childhood vaccination rates started to fall ahead of the onset of the second wave; this fall is accentuating ethnic, socioeconomic and geographical disparities in vaccine uptake and risks widening health disparities. Social distancing and school closures may have contributed to lower rates of associated VPDs, but there may be increased risk as these measures are removed.

Identifiants

pubmed: 35361613
pii: archdischild-2021-323630
doi: 10.1136/archdischild-2021-323630
pmc: PMC8983403
doi:

Substances chimiques

Measles-Mumps-Rubella Vaccine 0
Pneumococcal Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

733-739

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Uy Hoang (U)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Simon de Lusignan (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK simon.delusignan@phc.ox.ac.uk.

Mark Joy (M)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Julian Sherlock (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

John Williams (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Clare Bankhead (C)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Gary Howsam (G)

Royal College of General Practitioners, London, UK.

Mark Thomas (M)

Royal College of General Practitioners, London, UK.

Matthew D Snape (MD)

Paediatrics, University of Oxford, Oxford, UK.

F D Richard Hobbs (FDR)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Andrew J Pollard (AJ)

Paediatrics, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH